Furthermore, although the primary mutations in the initial course of GIST are in KIT/PDGFRA genes, new molecular changes during tumor progression determine the different clinical presentation and outcomes of patients [16]. The gene discussed is KIT; the disease is gastrointestinal stromal tumor.